Clinical Trials

The Association has always advocated participation in patient studies and other investigative medical initiatives.  Medical research and patient participation is necessary if medical science is to be advanced, and patient’s quality of life improved.

There are several clinical trials taking place on hypoparathyroidism at this time; too many to list here so we recommend you check out the  website or CenterWatch (see information below) for the complete list of current and upcoming research protocols.

We were asked by some of our Medical Advisors to post info on their resesarch protocols for your consideration and they are listed below.



Now Open: New study to understand the impact of hypoparathyroidism

Do you feel like your hypoparathyroidism symptoms are uncontrolled by your current treatment?

We have an online questionnaire for caregivers and adults with hypoparathyroidism who:

  • Are receiving calcium or vitamin D supplements as treatment
  • Still experiencing symptoms despite taking calcium or vitamin D supplements

The questionnaire aims to understand how hypoparathyroidism impacts your life and how you cope with it on a daily basis. To see if you qualify, visit

Do you have regular help and/or support from a friend or family member?

We would also like to hear from them too. In this survey we refer to this person as a caregiver, but this is a term for any family member or friend who may help you with regular activities, such as medication, grocery shopping, household chores, transportation, for example.  

The results will be used to understand how to treat hypoparathyroidism effectively and may be published in scientific literature. If you would like to take part in this industry-sponsored study, please follow the link. Many thank you in advance for your participation.



Now recruiting: medication injection device user study

If you are diagnosed with hypoparathyroidism or are a caregiver for someone with hypoparathyroidism, Radius is looking for study participants to evaluate a new injection device in the United States. The purpose of the study is to ensure that the device can be used safely and effectively.  

Who are we looking for? 

  • Patients and/or Caregivers of those diagnosed with Hypoparathyroidism who have never used an injection device


  • Patients and/or Caregivers who currently administer or previously administered NATPARA Q-Cliq Pen on a routine basis at home
  • You must be between the age of 18 to 65 years old
  • You must be willing and able to complete all required in-person sessions at one of the facilities listed below

Study Information  

  • You will NOT be interacting with any real drug at any point during the study.
  • You will NOT be injecting the placebo filled pen into yourself or anyone else. All injections will be a simulation and will be completed on an injection pad.
  • Depending on the enrollment group, you may be required to complete either: ONE 90 minute session OR TWO 60 minute sessions that will take place within 2 weeks of each other.
  • Study sessions will be held at the following facilities on the corresponding dates:
    • Dallas –  February 27th – March 1st AND March 13th – 15th
    • Orlando – March 6th – 8th AND March 20th – 22nd
    • Philadelphia - March 13th – 15th AND March 27th – 29th 
    • Chicago –  March 20TH – 22ND AND April 3th – 4th
  • All information gathered as part of this study will be kept anonymous. If you meet the study qualifications and are enrolled into this study, then you will be compensated for taking time out of your busy schedule to participate. The amount of compensation will be: $135 for the ONE 90 minute session OR $180 for the TWO 60 minute sessions.

If you are interested in participating in the study, please contact our principal investigator for additional information on enrollment at:

Investigator: Jessica Franklin at Radius Innovation & Development


Phone: +1 312 475 7740 



Has your medicine cabinet started to look like a pharmacy with all the pills and supplements you have for treating your hypoparathyroidism?

We invite you to learn more about the PARALLAX Study, a clinical research study measuring the safety and tolerability of an injectable study drug and its effects on calcium levels in the blood and the amount of calcium passed in the urine, in adults with hypoparathyroidism, when given once a day versus twice a day. The long-term goal of this continuing research is to improve calcium control and potentially to reduce patients’ daily doses and frequency of calcium and vitamin D supplements.

To learn more, visit

The PARALLAX Study is still actively recruiting. Several sites are now accepting patients and are in the process of adding more in the coming months. The sites that are active on our study website where patients who pass the online pre-screener can be referred are:

  • Columbia University – New York, NY
  • Providence Clinical Research – North Hollywood, CA
  • University of Chicago Medical Center – Chicago, IL
  • Diabetes & Metabolism Associates – Metarie, LA
  • Ohio State University – Columbus, OH
  • Thomas Jefferson University Diabetes Research Center – Philadelphia, PA
  • NOCCR – Knoxville, TN


Columbia Study



The divisions of Pediatric Endocrinology and Pediatric Nephrology at Mass General Hospital for Children (MGHfC) are pleased to announce the Pediatric Bone and Mineral Metabolism Disorders (BAMM) Clinic. The BAMM Clinic is a virtual, multidisciplinary clinic that provides care to infants, children and adolescents with conditions such as low bone density, osteoporosis, vitamin D deficiency, rickets and osteomalacia, hypoparathyroidism and other disorders that affect bone health and mineral metabolism.

Our providers work collaboratively with each child’s primary care provider, appropriate specialists and, most importantly, the child and family to ensure the highest quality of care. For older adolescents, our providers can facilitate a seamless transition from pediatric to adult care to ensure ongoing care for their bone health.

To learn more about the BAMM Clinic at MGHfC, including how to schedule an appointment and members of the care team, please visit  or call the Access and New Appointment Center at 888-644-3248. 



Harvard Medical School

Drs. Michael Mannstadt and Harald Jueppner are conducting a study of causes of familial forms of hypoparathyroidism.  They are looking for participants in which at 2 members of their family are affected by hypoparathyroidism.  For more information, click here.



CenterWatch Logo

 CenterWatch Clinical Trials Listing ServiceTM

CenterWatch first launched the Clinical Trials Listing Service in 1994 to assist patients in finding and volunteering for clinical trials. Today, CenterWatch has the largest online listing of actively recruiting clinical trials and is one of the most trusted resources for patients interested in clinical trial participation receiving more than 1.5 million unique patients visitors annually. To search our clinical trial listings and find other patient education resources 

Premium SSL Certificate